Nomura Asset Management CO LTD Krystal Biotech, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$174.7 - $213.66 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$153.12 - $183.64 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$108.01 - $179.35 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$96.0 - $128.29 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$108.51 - $130.22 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$78.48 - $130.32 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$72.39 - $84.27 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023
BUY
$63.14 - $79.9 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022
BUY
$64.85 - $82.4 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$64.85 - $82.4 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$64.85 - $82.4 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022
BUY
$48.93 - $73.47 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022
BUY
$51.99 - $72.11 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
BUY
$39.81 - $88.24 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
BUY
$52.01 - $71.77 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021
BUY
$62.14 - $81.82 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$59.42 - $85.46 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021
BUY
$40.64 - $61.38 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020
BUY
$37.76 - $48.49 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$37.03 - $60.0 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020
BUY
$35.02 - $65.64 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020
BUY
$33.17 - $65.23 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$34.72 - $51.3 $0 - $0
0 New
0 $0

Others Institutions Holding KRYS

# of Institutions
310
Shares Held
24.4M
Call Options Held
483K
Put Options Held
364K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.89B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email